Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. New AML drugs to accelerate genetic testing

    ... AML, MDS and MPN update: Dr David Steensma talks about the clinical implications of important new data sets ... Dr Steensma focused on a number of topics, his review of research in acute myeloid leukemia (AML) is perhaps most relevant because after ...

    Article last updated 09/25/2017 - 9:32am.

  2. A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients with Myelodysplastic Syndrome (MDS)

    For more details on this clinical trial, including contact information, please see this trial’s ... Purpose:  The goal of this clinical research study is to learn if azacitidine in combination with ...

    Clinical Trial last updated 05/14/2018 - 1:57pm.

  3. Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)

    For more details on this clinical trial, including contact information, please see this trial’s ... Purpose:  The goal of this clinical research study is to compare how 2 different drugs, decitabine and ...

    Clinical Trial last updated 05/14/2018 - 1:55pm.

  4. Professionals

    ... Congress in Washington, DC in May 2018, and is targeted to clinical nursing professionals in oncology. The program focuses on recent ... current areas of consensus and controversy, share recent research results, and identify the highest-priority directions for basic and ...

    Page last updated 05/04/2018 - 1:46pm.

  5. Foundation Update - July 2017

    ... June 17, the AAMDSIF Patient Advisory Council on Clinical Trials (PACCT+) members met in Arlington, Virginia for the second ... clinical trial design and the state of current MDS research. Learn more .   Young Aplastic ...

    Article last updated 10/09/2017 - 2:42pm.

  6. Gemtuzumab Receives New FDA Approval for Acute Myeloid Leukemia

    ... initially successful treatment. However, confirmatory clinical trials showed that the drug did not improve survival and was linked ... M.D., Ph.D., an AML specialist at Fred Hutchinson Cancer Research Center in Seattle. “The data for gemtuzumab benefiting at least some ...

    Research Article last updated 10/03/2017 - 12:56pm.

  7. Professionals

    ... and their families. MDS Clinical Research Consortium ...

    Page last updated 05/03/2018 - 2:28pm.

  8. Low Dose Danazol for the Treatment of Telomere Related Diseases

    For more details on this clinical trial, including contact information, please see this trial’s ... showed a positive influence on telomere length. Additional research is needed to learn more about the role of different doses of danazol ...

    Clinical Trial last updated 05/31/2018 - 2:53pm.

  9. Making Progress for Myelodysplastic Syndromes

    ... biggest challenge is finding enough patients to enroll in clinical trials that could help to advance treatment. But the Aplastic ... this by providing patients and patient data to support research. One of its efforts in this area is the MDS Clinical Research ...

    Article last updated 07/26/2017 - 10:25am.

  10. Foundation Update - October 2016

    ... specializing in MDS. The event focused primarily on MDS clinical updates, patient registries, transplantation and related bone ... Available Now: ASCO/EHA Research Summary The AAMDSIF 2016 ASCO/EHA Research ... presented at the 2016 meetings of the American Society of Clinical Oncology and the European Hematology Association, both held annually ...

    Article last updated 10/09/2017 - 2:49pm.